Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial
Titel:
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial
Auteur:
Saad, Fred Fizazi, Karim Jinga, Viorel Efstathiou, Eleni Fong, Peter C Hart, Lowell L Jones, Robert McDermott, Raymond Wirth, Manfred Suzuki, Kazuhiro MacLean, David B Wang, Ling Akaza, Hideyuki Nelson, Joel Scher, Howard I Dreicer, Robert Webb, Iain J de Wit, Ronald